ginsenoside rh2 has been researched along with Invasiveness, Neoplasm in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, N; Jin, X; Yang, Q; Zhang, Z | 1 |
| Liang, L; Sun, P; Wang, J; Wang, Z; Xu, M; Yuan, Y; Zhang, Y | 1 |
| Jin, YH; Li, H; Li, Y; Wang, YS; Zhang, S | 1 |
| Cui, CH; Hou, JG; Jeon, BM; Kim, SC; Yun, YJ | 1 |
| Fang, CY; Liang, ZH; Tang, GD; Tang, XP; Zhang, LY | 1 |
| Hong, B; Niu, T; Wu, S; Zhang, Q | 1 |
| Guan, N; Guo, W; Huo, X; Luo, J; Zhang, S; Zhang, Z | 1 |
| Han, SJ; Hyun, JW; Kim, DH; Kim, HS; Kim, SY | 1 |
8 other study(ies) available for ginsenoside rh2 and Invasiveness, Neoplasm
| Article | Year |
|---|---|
A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment.
Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Betulinic Acid; Biphenyl Compounds; Cell Proliferation; Cisplatin; Ginsenosides; Humans; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Pentacyclic Triterpenes; Sesquiterpenes; Triterpenes; Xenograft Model Antitumor Assays | 2020 |
20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial-mesenchymal transition.
Topics: Antineoplastic Agents; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; China; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Ginsenosides; Humans; Lymphatic Metastasis; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Signal Transduction; Vimentin | 2020 |
(20S)G-Rh2 Inhibits NF-κB Regulated Epithelial-Mesenchymal Transition by Targeting Annexin A2.
Topics: Annexin A2; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Ginsenosides; Humans; Neoplasm Invasiveness; NF-kappa B | 2020 |
Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A.
Topics: Apoptosis; Breast; Breast Neoplasms; Bystander Effect; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cellular Senescence; Doxorubicin; Epithelial Cells; Female; Ginsenosides; Humans; Interleukin-6; Neoplasm Invasiveness | 2019 |
Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Ginsenosides; Humans; Neoplasm Invasiveness; Pancreatic Neoplasms; Signal Transduction; Time Factors | 2013 |
Inhibition of prostatic cancer growth by ginsenoside Rh2.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Ginsenosides; Humans; Male; Mice; Neoplasm Invasiveness; Neoplasm Proteins; Prostatic Neoplasms; Receptors, Transforming Growth Factor beta; Signal Transduction | 2015 |
Ginsenoside Rh2 inhibits metastasis of glioblastoma multiforme through Akt-regulated MMP13.
Topics: Adult; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Ginsenosides; Glioblastoma; Humans; Male; Matrix Metalloproteinase 13; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Wound Healing | 2015 |
Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
Topics: Astrocytoma; Binding Sites; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Enzymologic; Ginsenosides; Humans; Matrix Metalloproteinase 1; Matrix Metalloproteinase 14; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Molecular Structure; Neoplasm Invasiveness; NF-kappa B; Phosphorylation; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; Tetradecanoylphorbol Acetate; Transcription Factor AP-1 | 2007 |